Objectives: Novel oral anticoagulants (NOACs) are increasingly used in patients with cardiovascular disease, but the impact in patients undergoing infrainguinal revascularization is not known. The objective of this study was to assess the contemporary use of NOACs after infrainguinal bypass and to assess the impact of NOACs on long-term graft and limb-related outcomes in comparison with warfarin.
Objectives: Plateletcrit (PCT) is a marker of total platelet mass and can easily be calculated from a complete blood count. High PCT has been reported to be associated with poor outcomes after coronary interventions. However, its association with peripheral interventions is unknown. We looked at the effect of PCT on outcomes of endovascular and open interventions for chronic limb ischemia.
Methods: Patients who underwent revascularization for chronic limb ischemia (Rutherford 3-6) between June 2001 and December 2014 were identified retrospectively. Based on preoperative PCT, patients were divided into tertiles: low (0.046-0.211), medium (0.212-0.271), and high (0.272-0.842) PCT groups. Patency and major adverse limb event rates were calculated using Kaplan-Meier and compared with log-rank. Cox regression was used for multivariate analysis.
Results: A total of 1431 patients were identified and divided into low (477), medium (477), and high (477) PCT groups. The median age was 66 years (range, 60-75 years) in the high PCT was compared with 67 years (range, 61-76 years) and 69 years (range, 63-79 years) in the medium and low PCT groups (P ¼ .009). Coronary artery disease and congestive heart failure were more prevalent in the low-PCT group compared with medium and high PCT group (coronary artery disease, 62% vs 51% and 50% [P < .001]; congestive heart failure: 13% vs 7% and 7% [P < .001]). The antiplatelet use was similar between groups. The 5-year primary patency was 51% 6 3% in the high PCT group compared with 65% 6 3% in low and 55% 6 3% in medium PCT groups (P ¼ .002; Fig) . The 5-year secondary patency was 72% 6 3% in the high PCT group compared with the 82% 6 2% in low and 8%2 6 3% in medium PCT groups (P ¼ .029). Freedom from major adverse limb event at 5 years was 47% 6 2% in the low PCT group as compared with 48% 6 3% in medium PCT and 39% 6 2% in high PCT groups (P ¼ .02). Multivariate regression analysis showed that chronic limb ischemia (hazard ratio, 1.7; 95% CI, 1.3-2.2; 
